Figure 3.
Figure 3. Twenty-hour donor platelet recoveries for platelets prepared from combined F-LR + γ-I treatments of PRP. (A) Two of 5 recipients (40%) accepted PLS-5A F-LR + γ-I platelets. There were no differences between means of pretreatment (43% ± 5%) and posttreatment (47% ± 2%) autologous platelet recoveries (P = .17) nor between pretreated and treated (49% ± 7%) autologous platelet recoveries (P = .51). (B) None of the 5 recipients accepted PL1-B F-LR + γ-I platelets. There were no differences between means of pretreatment (47% ± 6%) and posttreatment (51% ± 5%) autologous platelet recoveries (P = .19) nor between pretreated and treated (40% ± 20%) autologous platelet recoveries (P = .69).

Twenty-hour donor platelet recoveries for platelets prepared from combined F-LR + γ-I treatments of PRP. (A) Two of 5 recipients (40%) accepted PLS-5A F-LR + γ-I platelets. There were no differences between means of pretreatment (43% ± 5%) and posttreatment (47% ± 2%) autologous platelet recoveries (P = .17) nor between pretreated and treated (49% ± 7%) autologous platelet recoveries (P = .51). (B) None of the 5 recipients accepted PL1-B F-LR + γ-I platelets. There were no differences between means of pretreatment (47% ± 6%) and posttreatment (51% ± 5%) autologous platelet recoveries (P = .19) nor between pretreated and treated (40% ± 20%) autologous platelet recoveries (P = .69).

Close Modal

or Create an Account

Close Modal
Close Modal